Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium ScaffoldBusiness Wire • 10/22/26
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium ScaffoldBusiness Wire • 10/12/26
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ TechnologyBusiness Wire • 09/29/26
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of DirectorsBusiness Wire • 09/08/26
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026Business Wire • 09/04/26
Is TFX a Buy Now as Valuation Improves but Execution Risks Remain?Zacks Investment Research • 08/25/26
Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns?Zacks Investment Research • 08/24/26
Why Teleflex (TFX) International Revenue Trends Deserve Your AttentionZacks Investment Research • 08/10/26